Get the Stockscreener App
31.38
4.04%
-1.32
After Hours:
31.38
Astrana Health Inc stock is traded at $31.38, with a volume of 344.18K.
It is down -4.04% in the last 24 hours and up +2.55% over the past month.
Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company's three reportable segments are Care Partners, Care Delivery, and Care Enablement. It generates the majority of its revenue from the Care Partners segment.
See More
Previous Close:
$32.70
Open:
$32.37
24h Volume:
344.18K
Relative Volume:
1.02
Market Cap:
$1.54B
Revenue:
$1.72B
Net Income/Loss:
$62.46M
P/E Ratio:
24.14
EPS:
1.3
Net Cash Flow:
$69.89M
1W Performance:
-2.61%
1M Performance:
+2.55%
6M Performance:
-48.87%
1Y Performance:
-16.12%
1-Day Range:
$30.83
$33.03
1-Week Range:
$30.83
$34.15
52-Week Range:
$23.12
$63.20
Astrana Health Inc Stock (ASTH) Company Profile
Name
Astrana Health Inc
Sector
Industry
Phone
(626) 282-0288
Address
1668 S. GARFIELD AVENUE, ALHAMBRA
Compare ASTH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ASTH
Astrana Health Inc
|
31.38 | 1.54B | 1.72B | 62.46M | 69.89M | 1.30 |
|
HCA
Hca Healthcare Inc
|
335.01 | 83.86B | 70.60B | 5.76B | 5.64B | 21.97 |
|
FMS
Fresenius Medical Care Ag Adr
|
23.65 | 14.48B | 20.87B | 715.14M | 1.67B | 1.2209 |
|
DVA
Davita Inc
|
140.03 | 12.07B | 12.67B | 827.68M | 1.42B | 9.27 |
|
THC
Tenet Healthcare Corp
|
121.81 | 11.79B | 20.97B | 3.13B | 2.39B | 31.21 |
|
UHS
Universal Health Services Inc
|
174.80 | 11.66B | 15.42B | 1.03B | 956.84M | 15.02 |
Astrana Health Inc Stock (ASTH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-01-25 | Initiated | Barclays | Equal Weight |
| Oct-14-24 | Initiated | TD Cowen | Buy |
| Oct-11-24 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Jul-11-24 | Upgrade | Truist | Hold → Buy |
| May-30-24 | Initiated | Robert W. Baird | Outperform |
| Feb-26-24 | Initiated | Jefferies | Buy |
| Feb-22-24 | Upgrade | BofA Securities | Neutral → Buy |
| Jan-24-24 | Initiated | Stifel | Buy |
| Dec-22-23 | Initiated | Truist | Hold |
| Oct-17-23 | Initiated | BTIG Research | Buy |
| Apr-12-23 | Initiated | BofA Securities | Neutral |
| Dec-19-22 | Initiated | Lake Street | Buy |
| Sep-21-22 | Initiated | William Blair | Outperform |
| Jan-11-22 | Resumed | Colliers Securities | Buy |
| Aug-12-21 | Initiated | Barclays | Equal Weight |
View All
Astrana Health Inc Stock (ASTH) Latest News
Astrana Health Inc (NASDAQ: ASTH): Moving Toward A Higher Share Price - Stocksregister
Q4 Rundown: Astrana Health (NASDAQ:ASTH) Vs Other Healthcare Technology for Providers Stocks - Yahoo Finance
Astrana Health Earnings Alert: Key Q1 2025 Financial Results Coming May 8 - Stock Titan
Elanco Animal Health (ELAN) Soars 12.6%: Is Further Upside Left in the Stock? - Yahoo Finance
KLP Kapitalforvaltning AS Makes New $318,000 Investment in Astrana Health, Inc. (NASDAQ:ASTH) - MarketBeat
3 Growth Companies Insiders Back With Up To 21% Revenue Growth - simplywall.st
KLP Kapitalforvaltning AS Invests $318,000 in Astrana Health, Inc. (NASDAQ:ASTH) - The AM Reporter
Commit To Purchase Astrana Health At $22.50, Earn 12.5% Annualized Using Options - Nasdaq
Barclays initiates Astrana Health, noting risks on pending acquisition - TradingView
Astrana Health (NASDAQ:ASTH) Now Covered by Barclays - Defense World
Assessing Astrana Health: Insights From 6 Financial Analysts - Benzinga
Barclays Initiates Coverage of Astrana Health (ASTH) with Equal-Weight Recommendation - Nasdaq
Barclays Initiates Astrana Health at Equalweight With $36 Price Target - MarketScreener
Astrana Health appoints new Chief Accounting Officer By Investing.com - Investing.com Canada
Astrana Health Appoints New Chief Accounting Officer - TipRanks
Astrana Health appoints new Chief Accounting Officer - Investing.com
Charles Schwab Investment Management Inc. Increases Stake in Astrana Health, Inc. (NASDAQ:ASTH) - The AM Reporter
Truist Financial Issues Pessimistic Forecast for Astrana Health (NASDAQ:ASTH) Stock Price - The AM Reporter
Astrana Health (NASDAQ:ASTH) Price Target Cut to $46.00 by Analysts at Truist Financial - Defense World
2 Reasons to Like ASTH and 1 to Stay Skeptical - Yahoo Finance
Decoding Astrana Health Inc (ASTH): A Strategic SWOT Insight - GuruFocus
Astrana Health, Inc. SEC 10-K Report - TradingView
Q4 Earnings Review: Healthcare Technology for Providers Stocks Led by Phreesia (NYSE:PHR) - The Globe and Mail
Phreesia (PHR) To Report Earnings Tomorrow: Here Is What To Expect - The Globe and Mail
Astrana Health: Strategic Growth and Undervalued Opportunities Reinforce Buy Rating - TipRanks
Astrana Health Highlights Strategic Acquisition Plans - TipRanks
Insider Favorites For Growth In March 2025 - Yahoo Finance
Truist Financial Corp Buys New Holdings in Astrana Health, Inc. (NASDAQ:ASTH) - Defense World
Bank of America Has Lowered Expectations for Astrana Health (NASDAQ:ASTH) Stock Price - The AM Reporter
Astrana Health (NASDAQ:ASTH) Given New $49.00 Price Target at Bank of America - Defense World
Astrana Health, Inc. (NASDAQ:ASTH) Shares Sold by New York State Common Retirement Fund - Defense World
What 4 Analyst Ratings Have To Say About Astrana Health - Benzinga
Top Premarket Gainers - MarketScreener
Astrana Health (NASDAQ:ASTH) Price Target Cut to $50.00 by Analysts at Robert W. Baird - Defense World
BofA cuts Astrana Health target to $49, maintains Buy rating - Investing.com India
BofA cuts Astrana Health target to $49, maintains Buy rating By Investing.com - Investing.com South Africa
Truist maintains Buy rating, $50 target on Astrana Health stock By Investing.com - Investing.com South Africa
Truist maintains Buy rating, $50 target on Astrana Health stock - Investing.com
Astrana Health Updates Corporate Presentation for Conferences - TipRanks
Why Astrana Health (ASTH) Shares Are Sliding Today - MSN
Astrana Health, Inc. (NASDAQ:ASTH) Receives Average Recommendation of “Moderate Buy” from Analysts - Defense World
Astrana Health (NASDAQ:ASTH) Hits New 12-Month Low Following Weak Earnings - Defense World
Astrana Health, Inc. (ASTH) Reports Q4 Loss, Tops Revenue Estimates - MSN
Astrana Health, Inc. (NASDAQ:ASTH) Shares Sold by Rhumbline Advisers - Defense World
Astrana Health’s Earnings Call: Growth Amid Challenges - TipRanks
Why Astrana Health (ASTH) Shares Are Sliding Today By Stock Story - Investing.com Canada
Earnings call transcript: Astrana Health Q4 2024 misses EPS forecasts, revenue rises By Investing.com - Investing.com South Africa
Astrana Health, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2024 - Marketscreener.com
Astrana Health Inc Stock (ASTH) Financials Data
Revenue
Net Income
Cash Flow
EPS
Astrana Health Inc Stock (ASTH) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Chiang John | Director |
Nov 19 '24 |
Option Exercise |
18.41 |
1,515 |
27,891 |
17,364 |
| Sim Kenneth T. | Executive Chairman |
Nov 18 '24 |
Option Exercise |
18.65 |
28,046 |
523,058 |
609,905 |
| Marsh Linda | Director |
Sep 10 '24 |
Option Exercise |
15.35 |
11,000 |
168,850 |
80,714 |
| Lam Thomas S. | Director |
Sep 09 '24 |
Option Exercise |
18.65 |
28,046 |
523,058 |
409,901 |
| Kitayama Mitchell W | Director |
Sep 10 '24 |
Option Exercise |
15.35 |
11,000 |
168,850 |
21,314 |
| Chiang John | Director |
Sep 09 '24 |
Option Exercise |
15.35 |
11,000 |
168,850 |
19,414 |
| Schmidt David | Director |
Aug 14 '24 |
Option Exercise |
16.07 |
14,409 |
231,610 |
23,723 |
0.16%
0.06%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):